Recall of Cannabis for Medical Purposes – Aphria

Starting date:
January 25, 2018
Posting date:
January 30, 2018
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Labelling and Packaging
Audience:
General Public
Identification number:
RA-65848

Introduction

On January 25, 2018, Aphria, a licensed producer of cannabis for medical purposes located in Ontario, began a voluntary Type III recall of two lots of dried marijuana that were produced between January 19 and January 22, 2018. The affected lot number(s) are found below.

Reason

On January 25, 2018, Aphria initiated a voluntary Type III recall for two lots of dried marijuana sold in 10 g bottles, due to a labelling error. The labels omitted to indicate the percent sign (%) next to the numerical values for cannabinoid content.

A Type III recall refers to a situation in which the use of, or exposure to, a product is not likely to cause any adverse health consequences.

To date, Health Canada has not received any adverse reaction reports for products sold by Aphria. However, Health Canada recommends that any individual affected by the recall immediately stop using the recalled product and contact Aphria at the following number 1-844-427-4742.

Affected products

Dried marijuana

DIN, NPN, DIN-HIM
Not Applicable
Dosage form

Not Applicable

Strength

22.21% THC, <0.07% CBD

Lot or serial number

The following lots are classified under the Type III recall initiated on January 25, 2018.

1256-6712
1256-6714

Companies
Recalling Firm
Aphria
Ontario
CANADA
Tel: 1-844-427-4742
Marketing Authorization Holder
Not Applicable

Media enquiries

Health Canada
(613) 957-2983